- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Eris Lifesciences designates Gopal Agrawal, Nita Borkar in leadership roles

Mumbai: Eris Lifesciences Limited, an Indian branded formulations manufacturing company, has designated Gopal Agrawal and Nita Borkar in leadership roles in its flagship Domestic Branded Formulations business.
Gopal Agrawal has joined Eris as Vice President and will head up the Renal Care, Branded Injectables and Market Access business segments. Prior to joining Eris, Gopal was Director, Market Access at Takeda. Prior to Takeda, Gopal has worked with Shire Plc and Eli Lilly. He brings over three decades of rich experience in areas such as Sales, Market Access, Key Account & Tender Management, Pricing & Reimbursement, Public Affairs & Public Health Systems, Patient Advocacy & Services and Patient Support Programs. He holds a Bachelors’ degree in Science, a Masters’ degree in Electronics from Lucknow University and an MBA in Marketing from IGNOU.
Nita Borkar is the co-founder of Oaknet Healthcare and became part of the Eris organization following the acquisition of Oaknet by Eris in May 2022. Another pharma industry veteran, she co-founded Oaknet in Apr 2015, secured private equity funding for the business and built it into a successful player in the Dermatology space before divesting it to Eris back in 2022. She has now taken on a larger role in Eris and will spearhead the Dermatology, Neuropsychiatry and VMN businesses. Prior to co-founding Oaknet, Nita has worked with Lupin and Dabur across India, Asia Pacific and the Middle East. Nita holds a Bachelors’ degree in Microbiology and an MBA from Mumbai University.
Welcoming Gopal and Nita into their new roles, Amit Bakshi, Chairman and Managing Director, Eris Lifesciences said, “It is a real pleasure to have Gopal and Nita on board and taking on leadership roles in the business. Along with Murari who joined us last month to head the Cardiometabolic business, I am confident that our three new BU Leaders will bring their experience and expertise to bear and enable us to turbocharge the growth of our Domestic Formulations business over the next few years. I congratulate them on their new roles and wish them success.”
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751